Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Type
3.3. Snippet by Indication
3.4. Snippet by End-user
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing chronic diseases
4.1.2. Restraints
4.1.2.1. Adverse reactions to MRI contrast media agents
4.1.3. Opportunity
4.1.3.1. Technological advancements
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Analysis
9. By Product
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.1.2. Market Attractiveness Index, By Product
9.2. Paramagnetic Agents*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Superparamagnetic Agents
10. By Indication
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.1.2. Market Attractiveness Index, By Indication
10.2. Clinical*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Preclinical
11. By Indication
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
11.1.2. Market Attractiveness Index, By Indication
11.2. Cancer*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Gastrointestinal
11.4. Hepatobiliary
11.5. Neurological Imaging
11.6. Others
12. By End-user
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.1.2. Market Attractiveness Index, By End-user
12.2. Hospitals*
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Imaging Centers
12.4. Other
13. By Region
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.2. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.7.1. U.S.
13.2.7.2. Canada
13.2.7.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.7.1. Germany
13.3.7.2. U.K.
13.3.7.3. France
13.3.7.4. Italy
13.3.7.5. Spain
13.3.7.6. Rest of Europe
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.7.1. Brazil
13.4.7.2. Argentina
13.4.7.3. Rest of South America
13.5. Asia-Pacific
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.7.1. China
13.5.7.2. India
13.5.7.3. Japan
13.5.7.4. Australia
13.5.7.5. Rest of Asia-Pacific
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Product Benchmarking
14.3. Company Share Analysis
14.4. Key Developments and Strategies
15. Company Profiles
15.1. GE Healthcare*
15.1.1. Company Overview
15.1.2. Product Portfolio and Description
15.1.3. Financial Overview
15.1.4. Key Developments
15.2. Bracco Imaging SPA
15.3. Bayer AG
15.4. Guerbet
15.5. Lantheus Medical Imaging
15.6. Unijules Life Sciences
15.7. B. Chemicals and Pharmaceuticals Ltd.
15.8. SANOCHEMIA Pharmazeutika GmbH
15.9. Taejoon Pharm
15.10. Jodas Expoim
LIST NOT EXHAUSTIVE
16. Appendix
16.1. About Us and Services
16.2. Contact Us